Clinical Trials In Salt Lake

Discover hundreds of clinical trials in Salt Lake.
Search clinical trials in Salt Lake by condition or phase.

e.g. Respiratory Diseases

Salt Lake•Healthy volunteers: No

Filter results

Results: 1,142

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Salt Lake City, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting

Phase 3

Sponsor:

Melt Pharmaceuticals

Location:

Pleasant Grove, Chico, Grand Junction, Jacksonvilleshow 8 more

Code:

NCT06383273

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MELT-300 sublingual tablet

Midalozam sublingual tablet

Placebo sublingual tablet

A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Salt Lake City, Farmington, Boston, Durhamshow 3 more

Code:

NCT05095727

Conditions

Glycogen Storage Disease

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

mRNA-3745

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Salt Lake City, Phoenix, Scottsdale, Los Angelesshow 11 more

Code:

NCT04720976

Conditions

Solid Tumor

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-3312

Binimetinib

Pembrolizumab

Sotorasib

Osimertinib

Von Willebrand Factor in Pregnancy (VIP) Study

Recruiting

Sponsor:

University of Washington

Location:

Salt Lake City, Aurora, New Haven, Miamishow 7 more

Code:

NCT04146376

Conditions

Von Willebrand Diseases

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Use of a postpartum diary and additional blood draws

VWF replacement therapy with Wilate

Tranexamic acid

Use of a postpartum diary and additional blood draws.

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Recruiting

Phase 3

Sponsor:

RayzeBio, Inc.

Location:

Salt Lake City, Phoenix, Duarte, Irvineshow 25 more

Code:

NCT05477576

Conditions

GEP-NET

Gastroenteropancreatic Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor Disease

Neuroendocrine Tumors

Carcinoid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

Everolimus

Sunitinib

Octreotide

Lanreotide

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

United Therapeutics

Location:

Salt Lake City, Murray, Birmingham, Jaspershow 75 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

Restoration of Hypoglycemia Awareness With Metoclopramide

Recruiting

Phase 2

Sponsor:

Simon Fisher

Location:

Salt Lake City, Lexington

Code:

NCT03970720

Conditions

Hypoglycemia Unawareness

Eligibility Criteria

Sex: All

Age: 20 - 60

Healthy Volunteers: Not accepted

Interventions

Metoclopramide

Placebo

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting

Phase 3

Sponsor:

Janssen Research & Development, LLC

Location:

Salt Lake City, Tucson, Little Rock, Norwalkshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Salt Lake City, Los Angeles, Palo Alto, San Franciscoshow 6 more

Code:

NCT01196182

Conditions

Congenital Heart Defects

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

e.g. Respiratory Diseases

Salt Lake•Healthy volunteers: No

Filter results

Results: 1,142

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Salt Lake City, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Recruiting

Phase 3

Sponsor:

Melt Pharmaceuticals

Location:

Pleasant Grove, Chico, Grand Junction, Jacksonvilleshow 8 more

Code:

NCT06383273

Conditions

Cataract

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

MELT-300 sublingual tablet

Midalozam sublingual tablet

Placebo sublingual tablet

A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)

Recruiting

Phase 1

Phase 2

Sponsor:

Moderna

Location:

Salt Lake City, Farmington, Boston, Durhamshow 3 more

Code:

NCT05095727

Conditions

Glycogen Storage Disease

Eligibility Criteria

Sex: All

Age: 6+

Healthy Volunteers: Not accepted

Interventions

mRNA-3745

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Salt Lake City, Phoenix, Scottsdale, Los Angelesshow 11 more

Code:

NCT04720976

Conditions

Solid Tumor

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-3312

Binimetinib

Pembrolizumab

Sotorasib

Osimertinib

Von Willebrand Factor in Pregnancy (VIP) Study

Recruiting

Sponsor:

University of Washington

Location:

Salt Lake City, Aurora, New Haven, Miamishow 7 more

Code:

NCT04146376

Conditions

Von Willebrand Diseases

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Use of a postpartum diary and additional blood draws

VWF replacement therapy with Wilate

Tranexamic acid

Use of a postpartum diary and additional blood draws.

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Recruiting

Phase 3

Sponsor:

RayzeBio, Inc.

Location:

Salt Lake City, Phoenix, Duarte, Irvineshow 25 more

Code:

NCT05477576

Conditions

GEP-NET

Gastroenteropancreatic Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor Disease

Neuroendocrine Tumors

Carcinoid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

Everolimus

Sunitinib

Octreotide

Lanreotide

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Recruiting

Phase 3

Sponsor:

United Therapeutics

Location:

Salt Lake City, Murray, Birmingham, Jaspershow 75 more

Code:

NCT04708782

Conditions

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Placebo

Inhaled Treprostinil

Treprostinil Ultrasonic Nebulizer

Restoration of Hypoglycemia Awareness With Metoclopramide

Recruiting

Phase 2

Sponsor:

Simon Fisher

Location:

Salt Lake City, Lexington

Code:

NCT03970720

Conditions

Hypoglycemia Unawareness

Eligibility Criteria

Sex: All

Age: 20 - 60

Healthy Volunteers: Not accepted

Interventions

Metoclopramide

Placebo

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting

Phase 3

Sponsor:

Janssen Research & Development, LLC

Location:

Salt Lake City, Tucson, Little Rock, Norwalkshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

Congenital Heart Disease GEnetic NEtwork Study (CHD GENES)

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Salt Lake City, Los Angeles, Palo Alto, San Franciscoshow 6 more

Code:

NCT01196182

Conditions

Congenital Heart Defects

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted